Member Info for potnak

I understand the feeling here but how you know there isn't any large phama interested? If there is an NDA in place, SAR wouldn't be able to say anything. a good example of this type of scenario is the PYC deal with Merck last year. It turned out that they'd been working with Merck for 5 years before announcing it. My guess is Tim and co already know who the TYK2 deal will be with but it will depend on us meeting some developmental milestones. Patents, preclinical data etc.. and if that is the case, there will be a watertight NDA in place.

Fast - MM's are there to make the market. They show buys as sell and vice versa to encourage punters to buy or sell depending on the flow of trades. There are no games, it's how it works. Without the MM's you'd never be able to take profit. For you to take a profit, they have to convince some other punter to buy on a spike.

Yes, I've read that over a few times now! that's why I'm buying on the dip today. This paragraph makes us a T/O target IMO.

I bought a few more. Only �2k but I see it as a no-brainer at this price. I will, however, sell into any spike in the next few weeks. I have a funny feeling the delay was still justified.

Not deramping. Just confused why everyone is so excited. It's an existing collaboration which will bring in 250k in the next 4 to 6 months. You can call it what you like but I'm selling into the spike if it happens.

They did this on the year end report too. It's all good but it's still a year away. It was always going to be 2019 but I don't mind this board getting excited for a bit.

Wish one of you guys were right, just once but this is just what I expected. Back to sleep.

From Aligns own page. RISK WARNING & DISCLAIMER Hemogenyx is a research client of Align Research. Align Research owns shares in Hemogenyx. For full disclaimer information please refer to the last page of the full document. This investment may not be suitable for your personal circumstances. If you are in any doubt as to its suitability you should seek professional advice. This note does not constitute advice and your capital is at risk. This is a marketing communication and cannot be considered independent research.

Obviously pure speculation but if there is news due before the interims and it contains CHK1 news. I believe this will be timed with SRRA opening rather than the AIM market. So I'd expect this to come intraday. If the 'news' isn't CHK1 related we'll get an RNS at 7:00 am unless it's a licence agreement or similar then it'll come when it's announced. Or the interims will just be released, we'll get an update and that's it. I'm certain on one thing though. Nothing major will be released in the interims. That isn't what they are for. Clear as mud. I'm optimistic but only because I'm easily pleased.

I always give SAR and the board the benefit of the doubt and believe my money is in one of the safest AIM companies there is but that's only because I stated to buy at the bottom. Can't say I'd feel that way if I'd bought on a spike. But reading your point in black and white Num, makes me think we should be giving the board a harder time? It won't be long before we are in Q2 2018 so your dates don't make for good reading. Roll on Monday indeed.

I'm in agreement Andy. Except I don't think the other compounds have moved on sufficiently enough to get excited about. I also think if the update has CHK1 news, it will be released intraday when SRRA opens for trading. With that thinking and with my glass half full hat on, we could get an RNS anytime from now until mid March, i'm thinking the longer we wait the better the news. Just because why wait? unless you are waiting for something specific?

My glass is half full here, I am positive about our future. Happy to wait it out but I honestly believe we delayed the interims because we didn't know what was in the SRRA update. I did think it might be for milestones to be announced but that is getting less likely now. I think our interim report will be padded out with the CHk1 stuff to hide the fact that other compounds haven't moved on.

Spot on visainn. The company are complicit in this manipulation too! They knew what the first tweet would do. I was watching for a buy in but not a chance until this game has played out.

Or shelve Aurora FLT? Odds on 1,2 or all compounds failing is still very high. Its the nature of biotech.

I'm as optimistic as I ever was. I'm in profit though which helps. I also work on 2019 being our year so I still have a year to go before I get worried. I'm also only after 3 to 5p. I'd love 28p but I just don't think it will happen. Although, I fully understand why others think it will.

Or there is something to shout about but there is an NDA in place. Tim Mitchell said it best when he said "no news is good news"

Said first 2 weeks in March. We've only had 1. The interims will be a boring update. Just read last year's. It's what comes before or after what's important. Think some on this board need something else to do for a bit.

It was delayed because SAR didn't know what was in the SRRA update. I believe it was that simple. With the CHK1 stuff. There isn't much else to report on. Back to sleep until April.

1 and 6 are the only plausible explanations. The other dates would be hard to pin down down to a day/week. If it is 6. They could just regurgitate last year's results. Still waiting on Aurora and TYK2 blah blah blah.

Maybe, I thought milestones last week but we would have known about by now. If you read last years and take out the CHK1 stuff, it could be a sparse update so maybe there is something coming beforehand?